6646-49-7

Upstream product

• 82191-15-9 C₁₁H₁₃N₃O₃S 
• 2227-64-7 3'-nitro-2-bromoacetophenone 
• 83846-64-4 2-(2-imino-thiazolidin-3-yl)-1-(3-nitro-phenyl)-ethanone 
• 6649-52-1 2-(2-acetylimino-thiazolidin-3-yl)-1-(3-nitro-phenyl)-ethanone 

Downstream Products

• 791007-46-0 (6R)-(3-nitrophenyl)-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole 
• 59548-89-9 (6S)-(3-nitrophenyl)-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole 

Relevant academic research and scientific papers

ANTHELMINTIC IMIDAZOL-THIAZOLE DERIVATES

The present invention relates to the novel anthelmintic compound tetrahydro-furan-2- carboxylic acid-[3-(2,3,5,6-tetrahydro-imidazo[2,1-b]thiazol-6-yl)-phenyl]-amide and the pharmaceutically acceptable acid addition salts and the stereochemically isomeric forms thereof, as well as pharmaceutical compositions comprising said novel compound, processes for preparing said compound and compositions, and the use thereof as a medicine, in particular in treatment, control and prevention of endo- and ectoparasite infections in warm-blooded animals.

6-Substituted amino phenyl-2,3,5,6-tetrahydro[2,1-b]thiazoles

The preparation of dl and l compounds of the type 6-(mono and di-substituted phenyl)-5,6-dihydro or 2,3,5,6-tetrahydroimidazo[2,1-b]thiazoles and the pharmaceutically acceptable salts thereof, is described. The use of said compounds for treating helminthiasis in warm-blooded animals is also described.